SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022287
Filing Date
2020-08-14
Accepted
2020-08-14 16:28:13
Documents
42
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_wizepharma.htm 10-Q 441007
2 LETTER AGREEMENT (SPA), DATED JUNE 24, 2020, BY AND BETWEEN THE COMPANY AND BONU f10q0620ex10-1_wize.htm EX-10.1 16179
3 AMENDMENT TO LETTER AGREEMENT (SPA), DATED JULY 1, 2020, BY AND BETWEEN THE COMP f10q0620ex10-2_wize.htm EX-10.2 10061
4 CERTIFICATION f10q0620ex31-1_wize.htm EX-31.1 7901
5 CERTIFICATION f10q0620ex31-2_wize.htm EX-31.2 7795
6 CERTIFICATION f10q0620ex32-1_wize.htm EX-32.1 4321
7 CERTIFICATION f10q0620ex32-2_wize.htm EX-32.2 4140
  Complete submission text file 0001213900-20-022287.txt   2088283

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE wizp-20200630.xml EX-101.INS 339183
9 XBRL SCHEMA FILE wizp-20200630.xsd EX-101.SCH 33451
10 XBRL CALCULATION FILE wizp-20200630_cal.xml EX-101.CAL 30338
11 XBRL DEFINITION FILE wizp-20200630_def.xml EX-101.DEF 64105
12 XBRL LABEL FILE wizp-20200630_lab.xml EX-101.LAB 170436
13 XBRL PRESENTATION FILE wizp-20200630_pre.xml EX-101.PRE 119412
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 201105551
SIC: 2834 Pharmaceutical Preparations